catechol has been researched along with Breast Cancer in 10 studies
Excerpt | Relevance | Reference |
---|---|---|
"The antiestrogen, tamoxifen, has been extensively used in the treatment and prevention of breast cancer." | 3.72 | Antiestrogenic and DNA damaging effects induced by tamoxifen and toremifene metabolites. ( Bolton, JL; Burdette, JE; Li, Y; Liu, X; Pisha, E; Tonetti, DA; Yao, D; Yao, J, 2003) |
"Human breast adenocarcinoma MCF-7/0 cells and a stably oxazaphosphorine-resistant subline thereof, MCF-7/OAP, were grown in the presence of 3-methylcholanthrene (3 microM), catechol (30 microM), or vehicle for 5 days." | 3.69 | Multienzyme-mediated stable and transient multidrug resistance and collateral sensitivity induced by xenobiotics. ( Rekha, GK; Sladek, NE, 1997) |
"Pakinson diseases, schizophrenia, and breast cancer." | 1.43 | [The relationship between catechol O-methyltransferase and diseases]. ( Bi, XL; Dou, TY; Ge, GB; Hou, J; Ma, H; Qian, XK; Xia, YL; Yang, L, 2016) |
"Estrogen exposure is a risk factor for breast cancer, and estrogen oxidative metabolites have been implicated in chemical carcinogenesis." | 1.35 | Selective estrogen receptor modulator delivery of quinone warheads to DNA triggering apoptosis in breast cancer cells. ( Bolton, JL; Lu, M; Peng, KW; Qin, Z; Thatcher, GR; Wang, H; Wang, Z; Wijewickrama, GT, 2009) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (20.00) | 18.2507 |
2000's | 4 (40.00) | 29.6817 |
2010's | 4 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Amani, J | 1 |
Khoshroo, A | 1 |
Rahimi-Nasrabadi, M | 1 |
Qian, XK | 1 |
Xia, YL | 1 |
Dou, TY | 1 |
Hou, J | 1 |
Ma, H | 1 |
Ge, GB | 1 |
Yang, L | 1 |
Bi, XL | 1 |
Zhu, J | 1 |
Huo, Q | 1 |
Xu, M | 1 |
Yang, F | 1 |
Li, Y | 2 |
Shi, H | 1 |
Niu, Y | 1 |
Liu, Y | 1 |
Peng, KW | 1 |
Wang, H | 1 |
Qin, Z | 1 |
Wijewickrama, GT | 1 |
Lu, M | 1 |
Wang, Z | 1 |
Bolton, JL | 3 |
Thatcher, GR | 1 |
Fernandes, I | 1 |
Faria, A | 1 |
Azevedo, J | 1 |
Soares, S | 1 |
Calhau, C | 1 |
De Freitas, V | 1 |
Mateus, N | 1 |
Liu, X | 1 |
Pisha, E | 1 |
Tonetti, DA | 1 |
Yao, D | 2 |
Yao, J | 1 |
Burdette, JE | 1 |
Castagnetta, L | 1 |
Granata, OM | 1 |
Cocciadiferro, L | 1 |
Saetta, A | 1 |
Polito, L | 1 |
Bronte, G | 1 |
Rizzo, S | 1 |
Campisi, I | 1 |
Agostara, B | 1 |
Carruba, G | 1 |
Rekha, GK | 2 |
Sladek, NE | 2 |
Zhang, F | 1 |
Hua, Y | 1 |
van Breemen, RB | 1 |
1 review available for catechol and Breast Cancer
Article | Year |
---|---|
Sex steroids, carcinogenesis, and cancer progression.
Topics: Adsorption; Androstenedione; Animals; Breast Neoplasms; Catalysis; Catechols; Cell Line, Tumor; Chro | 2004 |
9 other studies available for catechol and Breast Cancer
Article | Year |
---|---|
Electrochemical immunosensor for the breast cancer marker CA 15-3 based on the catalytic activity of a CuS/reduced graphene oxide nanocomposite towards the electrooxidation of catechol.
Topics: Antigens, Neoplasm; Breast Neoplasms; Catalysis; Catechols; Copper; Electrochemical Techniques; Grap | 2017 |
[The relationship between catechol O-methyltransferase and diseases].
Topics: Breast Neoplasms; Catechol O-Methyltransferase; Catechols; Dopamine; Epinephrine; Estradiol; Humans; | 2016 |
Bortezomib-catechol conjugated prodrug micelles: combining bone targeting and aryl boronate-based pH-responsive drug release for cancer bone-metastasis therapy.
Topics: Alendronate; Animals; Antineoplastic Agents; Bone Neoplasms; Bortezomib; Breast Neoplasms; Catechols | 2018 |
Selective estrogen receptor modulator delivery of quinone warheads to DNA triggering apoptosis in breast cancer cells.
Topics: Apoptosis; Breast Neoplasms; Caspase 3; Caspase 7; Catechols; Cell Line, Tumor; DNA Damage; Female; | 2009 |
Influence of anthocyanins, derivative pigments and other catechol and pyrogallol-type phenolics on breast cancer cell proliferation.
Topics: Anthocyanins; Breast Neoplasms; Catechols; Cell Proliferation; Female; Gene Expression Regulation, N | 2010 |
Antiestrogenic and DNA damaging effects induced by tamoxifen and toremifene metabolites.
Topics: Binding, Competitive; Breast Neoplasms; Catechols; Cell Line, Tumor; Cell Survival; Comet Assay; DNA | 2003 |
Inhibition of human class 3 aldehyde dehydrogenase, and sensitization of tumor cells that express significant amounts of this enzyme to oxazaphosphorines, by the naturally occurring compound gossypol.
Topics: Adenocarcinoma; Aldehyde Dehydrogenase; Antineoplastic Agents, Alkylating; Breast Neoplasms; Catecho | 1997 |
Multienzyme-mediated stable and transient multidrug resistance and collateral sensitivity induced by xenobiotics.
Topics: Adenocarcinoma; Aldehyde Dehydrogenase; Antineoplastic Agents; Breast Neoplasms; Carcinogens; Catech | 1997 |
Synthesis and reactivity of the catechol metabolites from the equine estrogen, 8,9-dehydroestrone.
Topics: Animals; Breast Neoplasms; Catechols; DNA Adducts; Estrogens, Conjugated (USP); Estrone; Female; Hum | 2001 |